Clinical trials
Phase 2/3 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 7 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mandos LLC | 2 |
| University Health Network, Toronto | 2 |
| AO GENERIUM | 1 |
| AgeneBio | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Anne Comi, MD | 1 |
| Avid Radiopharmaceuticals | 1 |
| Beijing Tiantan Hospital | 1 |
| Charite University, Berlin, Germany | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 31 |
| Alzheimer Disease | 4 |
| Schizophrenia | 3 |
| Cognition Disorders | 2 |
| Deglutition Disorders | 2 |
| Dementia, Vascular | 2 |
| Disease | 2 |
| Memory Disorders | 2 |
| Mental Disorders | 2 |
| Mobility Limitation | 2 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.